B−82/100
Graded #6Editorial review
Found
Aggressive identical pricing on both molecules, wrapped in a coaching-first program.
Visit Found ↗Editorial review — no commercial relationship.
- Semaglutide
- $129/mo
- Tirzepatide
- $129/mo
- Coverage
- All 50 states
- Brand-name
- Compounded only
Factor breakdown
Each of the six graded dimensions. See the methodology.
Cost value90/100
Dose & formulation80/100
Clinical oversight82/100
Labs & monitoring80/100
Fulfillment82/100
Contract terms78/100
Strengths
- Low identical pricing on both molecules
- Nationwide
- Strong coaching
Where it loses points
- Subscription coaching model isn't for everyone
- Compounded only
Bottom line — Grade B−
Best for: People who want behavior-change coaching bundled with medication.
Pricing/verification reflect Found's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on Found's site. Not medical advice; see our disclosure.